Voyager Acquisition Corp Class A Ordinary Shares (VACH) is a publicly traded Financial Services sector company. As of May 21, 2026, VACH trades at $11.01 with a market cap of $301.39M and a P/E ratio of 0.00. VACH moved -0.19% today. Year to date, VACH is +3.19%; over the trailing twelve months it is +7.00%. Its 52-week range spans $8.40 to $15.68. Rallies surfaces VACH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Voyager Acquisition Approves Veraxa Merger with 99.67% Redemption, $885,556 Remaining: Voyager Acquisition Corporation shareholders approved a business combination with Veraxa Biotech AG, redeeming 25,217,315 Class A shares—99.67% of total outstanding—leaving $885,556 in its trust account. If no redemption withdrawals occur, 82,685 Class A shares convert into shares of combined Veraxa Biotech Holding AG, listing on Nasdaq under ticker VRXA pending approvals.
| Metric | Value |
|---|---|
| Price | $11.01 |
| Market Cap | $301.39M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.68 |
| 52-Week Low | $8.40 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $8.99M |
| Gross Margin | 0.00% |
VACH analyst coverage data. Average price target: $0.00.